The Comparion of Pregnancy Outcomes between GnRH Agonist and GnRH Antagonist Cycles in Women with Advanced Age |
Park, Chan Woo
(Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Samsung Cheil Hospital and Women's Healthcare Center, Sungkyunkwan University School of Medicine)
Cha, Sun Wha (Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Samsung Cheil Hospital and Women's Healthcare Center, Sungkyunkwan University School of Medicine) Kim, Hae Suk (Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Samsung Cheil Hospital and Women's Healthcare Center, Sungkyunkwan University School of Medicine) Kim, Hye Ok (Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Samsung Cheil Hospital and Women's Healthcare Center, Sungkyunkwan University School of Medicine) Yang, Kwang Moon (Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Samsung Cheil Hospital and Women's Healthcare Center, Sungkyunkwan University School of Medicine) Kim, Jin Young (Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Samsung Cheil Hospital and Women's Healthcare Center, Sungkyunkwan University School of Medicine) Song, In Ok (Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Samsung Cheil Hospital and Women's Healthcare Center, Sungkyunkwan University School of Medicine) Yoo, Keun Jae (Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Samsung Cheil Hospital and Women's Healthcare Center, Sungkyunkwan University School of Medicine) Kang, Inn Soo (Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Samsung Cheil Hospital and Women's Healthcare Center, Sungkyunkwan University School of Medicine) Koong, Mi Kyoung (Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Samsung Cheil Hospital and Women's Healthcare Center, Sungkyunkwan University School of Medicine) |
1 | Garcia-Velasco JA, Isaza V, Requena A, MartfnezSalazar F, Landazabal A, Remohf J, et al. High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial. Hum Reprod 2000; 15: 2292-6 DOI ScienceOn |
2 | Garcia J, Padilla S, Bargati J, Baramki T. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for in vitro fertilization. Fertil Steril 1990; 53: 302-5 |
3 | Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, et al. Incidence of early loss of pregn.ancy. N Engl J Med 1988; 319: 189-94 DOI ScienceOn |
4 | Navot D, Drews MR, Bergh PA, Guzman I, Karstaedt A, Scott RT, et al. Age-related decline in female fertility is not due to diminished capacity of the uterus to sustain embryo implantation. Fertil Steril 1994; 61: 97-101 |
5 | Akman MA, Erden HF, Tosun SB, Bayazit N, Aksoy E, Bahceci M. Comparison of agonistic flare-upprotocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial. Hum Reprod 2001; 16: 868-70 DOI ScienceOn |
6 | Fasouliotis Sl, Laufer N, Sabbagh-Ehrlich S, Lewin A, Hurwitz A, Simon A. Gonadotropin-releasing hormone (GnRH)-antagonist versus GnRH-agonist in ovarian stimulation of poor responders undergoing IVE. J Assist Reprod Genet 2003; 20: 455-60 DOI ScienceOn |
7 | Kleinman D, Karas M, Danilenko M, Arbell A, Roberts CT, LeRoith D, et al. Stimulation of endometrial cancer cell growth by tamoxifen is associated with increased IGF-I induced tyrosine phosphorylation and reduction in IGF binding proteins. Endocrinology 1996; 137: 1089-95 DOI ScienceOn |
8 | Lin Y,Kahn JA, Hillensjo T. Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophinreleasing hormone antagonist? Hum Reprod 1999; 14: 885-8 DOI ScienceOn |
9 | Ortmann O, Oltmanns K, Weiss JM, et al. Effects of the GnRH antagonist Cetrorelix on steroidogenesis in human granulosa lutein cells. Hum Reprod 1998; 13(Abstract Book), P-252 |
10 | Stirrat GM. Recurrent miscarriage. Lancet 1990; 336: 673-5 DOI PUBMED ScienceOn |
11 | Dekel N, Lewysohn O, Ayalon D, Hazum E. Receptor for GnRH are present in rat oocytes. Endocrinology 1988; 123: 1205-7 DOI ScienceOn |
12 | Scott RT, Navot D. Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization. Fertil Steril 1994; 61: 880-5 |
13 | Feldberg D, Farhi J, Ashkenazi J, Dicker D, Shalev J, Ben Rafael Z. Minidose gonadotropin releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels. Fertil Steril 1994; 62: 343-6 |
14 | Minaretzis D, Alper MM, Oskowitz SP, Lobel SM, Mortola JF, Pavlou SN. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa lutein cells. Am J Obstet Gynecol 1995a; 172: 1518-25 DOI ScienceOn |
15 | Hermann R, Scheider E, Romeis P. Pharmacokinetics and pharmacodynamics of the LH-RH-antagonist Cetrorelix in healthy male and female subjects. Gynecol Endocrinol 1996; 10 (suppl. 1): 9-15 DOI ScienceOn |
16 | Nikolettos N, Al-Hasani S, Felberbaum R, Demirel LC, Kupker W, Montzka P, et al. Gonadotropinreleasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders. Eur J Obstet Gynecol Reprod Biol 2001; 97: 202-7 DOI ScienceOn |
17 | Toth T, Awwad J, Veeck L, Jones H, Muasher S. Suppression and flare regimens of gonadotropinreleasing hormone agonist: use in women with different basal gonadotropin values in an in vitro fertilization program. J Reprod Med 1996; 41: 321-6 |
18 | Katayama K, Roesler M, Gunnarson G, Stehlik E, Jagusch S. Short-term use of gonadotropin-releasing hormone agonist (leuprolide) for in vitro fertilization. J In Vitro Fert Embryo Transfer 1988; 5: 332-7 DOI ScienceOn |
19 | Latouche J, Crumeyrolle-Arias M, Jordan D, Kopp N, Augendre-Ferrante B, Cedard L, et al. GnRH receptors in human granulosa cells: anatornicallocalization and characterization by autoradiographic study. Endocrinology 1989; 125: 1739-41 DOI ScienceOn |
20 | Hershkovitz E, Marbach M, Bosin E, Levy J, Roberts CT Jr, LeRoith D, et al. Luteinizing hormonereleasing hormone antagonists interfere with autocrine and paracrine growth stimulation of MCF-7 mammary cancer cells by insulin-like growth factors. J Clin Endocrinol Metab 1993; 77: 963-8 DOI ScienceOn |
21 | Mohamed KA, Davies WA, Allsopp J, Lashen H. Agonist 'flare-up' versus antagonist in the management of poor responders undergoing in vitro fertilization treatment. Fertil Steril 2005; 83: 331-5 DOI ScienceOn |
22 | Muasher SJ. Controversies in assisted reproduction: treatment of low responders. J Assist Reprod Genetics 1993; 10: 112-4 DOI PUBMED ScienceOn |
23 | Tasdemir M, Tasdemir I, Kodama H, Fukuda J, Tanaka T. Short protocol of gonadotropin releasing hormone agonist administration gave better results in long protocol poor-responders in lVF-ET. Obstet Gynaecol 1996; 22: 73-7 |
24 | 박찬우, 궁미경, 양광문, 김진영, 유근재, 서주태 등. 폐쇄성 무정자증과 비폐쇄성 정자증에서 체외수정시술의 후의 임신 결과 비교. 대한불임회지 2003;30:207-15 |
25 | Barnhart K, Dunsrnoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilization. Fertil Steril 2002; 77: 1148-55 DOI ScienceOn |